Lupin Strengthens Sustainability with Sunsure Solarpark Equity Acquisition

Lupin Finalizes Equity Acquisition of Sunsure Solarpark

Lupin Limited (NSE: LUPIN), a leading pharmaceutical company, has completed its equity acquisition in Sunsure Solarpark Seventeen Private Limited (“Sunsure Solarpark”). This strategic move reflects Lupin’s dedication to sustainability and operational excellence.

Key Acquisition Highlights

• Equity Stake: Lupin has acquired 42.61% of Sunsure Solarpark’s equity share capital.
• Completion Date: The acquisition was finalized on January 9, 2025, completing a two-tranche transaction initiated in September 2024.
• Investment Value: The total consideration did not exceed Rs. 105.53 million.
• Captive User Role: Lupin’s stake positions it as a Captive User, enabling the company to utilize solar energy for its operations.

Strategic Benefits

1. Advancing Sustainability: The acquisition reinforces Lupin’s commitment to reducing its carbon footprint through renewable energy adoption.
2. Cost Optimization: Access to solar energy can result in significant energy cost savings, enhancing profitability.
3. Operational Stability: A steady supply of renewable energy supports efficient and reliable operations across Lupin’s facilities.

About Sunsure Solarpark

Sunsure Solarpark specializes in solar energy generation, aligning with Lupin’s sustainability goals. While operational specifics remain undisclosed, its potential to contribute to Lupin’s green energy initiatives is evident.

Lupin’s Sustainable Vision

This acquisition demonstrates Lupin’s proactive approach toward environmental responsibility. By leveraging solar energy, Lupin aims to build a sustainable future, enhance efficiency, and promote eco-friendly practices across its operations. This move underscores Lupin’s commitment to balancing business growth with environmental stewardship.